SAN DIEGO , May 30, 2023 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced its participation in the William Blair 43 r d Annual Growth Stock Conference , which takes place June 6-8, 2023 , in Chicago at the Loews Chicago Hotel .

Record Physician Demand for AVISE® CTD SAN DIEGO , May 15, 2023 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN)("Exagen"), a leading provider of autoimmune testing solutions, today reported financial results for the quarter ended March 31, 2023 . First Quarter Highlights: Delivered a record 37,312

SAN DIEGO , May 01, 2023 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced, in recognition of Lupus Awareness Month, the launch of a campaign focusing on providers, patients and partnership activities that enhance the impactful work

SAN DIEGO , April 24, 2023 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, will release financial results for the quarter ended March 31, 2023 , after the market close on Monday, May 15, 2023 . John Aballi , Exagen’s President and Chief Executive

Record AVISE® CTD Volume in 2022 SAN DIEGO , March 20, 2023 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today reported financial results for the fourth quarter and full year ended December 31, 2022 .

SAN DIEGO , March 06, 2023 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, will release financial results for the quarter and year ended December 31, 2022 , after the market close on Monday, March 20, 2023 .

SAN DIEGO , Feb. 27, 2023 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced that management will participate in the following March investor conferences. Cowen 43 rd Annual Health Care Conference March 6-8, 2023 , at the Boston

SAN DIEGO , Jan. 30, 2023 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced its participation in the BTIG MedTech, Digital Health , Life Science & Diagnostic Tools Conference , which takes place February 14-16, 2023 in Snowbird, UT .

SAN DIEGO , Jan. 23, 2023 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, announced today that Tina S. Nova , Ph.D. has been elected as Executive Chair of the Exagen Board of Directors, effective January 19, 2023 . Dr.